Congruence Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference

MONTREAL, Sept. 6, 2023 /CNW/ -- Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecule correctors for diseases of

Related Keywords

Montreal ,Quebec ,Canada ,Charles Grubsztajn ,Clarissa Desjardins ,Amy Conrad ,Company Contact ,Morgan Stanley ,Annual Global Healthcare Conference ,Business ,